Clinical trials
Recruiting Macular Degeneration trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 2 |
| 4D Molecular Therapeutics | 1 |
| Azienda Ospedaliera Universitaria Mater Domini, Catanzaro | 1 |
| Complement Therapeutics | 1 |
| EyeBiotech Ltd. | 1 |
| Janssen Research & Development, LLC | 1 |
| ONL Therapeutics | 1 |
| Regeneron Pharmaceuticals | 1 |
| Sitala Bio LTD | 1 |
| University of Edinburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 12 |
| Geographic Atrophy | 7 |
| Wet Macular Degeneration | 2 |
| Anxiety Disorders | 1 |
| Choroidal Neovascularization | 1 |
| Cognitive Dysfunction | 1 |
| Frailty | 1 |
| Vision Disorders | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.